Lai, H.-C.; Lin, J.-F.; Hwang, T.I.S.; Liu, Y.-F.; Yang, A.-H.; Wu, C.-K.
Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword? Int. J. Mol. Sci. 2019, 20, 2194.
https://doi.org/10.3390/ijms20092194
AMA Style
Lai H-C, Lin J-F, Hwang TIS, Liu Y-F, Yang A-H, Wu C-K.
Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword? International Journal of Molecular Sciences. 2019; 20(9):2194.
https://doi.org/10.3390/ijms20092194
Chicago/Turabian Style
Lai, Hung-Chih, Ji-Fan Lin, Thomas I.S. Hwang, Ya-Fang Liu, An-Hang Yang, and Chung-Kuan Wu.
2019. "Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?" International Journal of Molecular Sciences 20, no. 9: 2194.
https://doi.org/10.3390/ijms20092194
APA Style
Lai, H. -C., Lin, J. -F., Hwang, T. I. S., Liu, Y. -F., Yang, A. -H., & Wu, C. -K.
(2019). Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword? International Journal of Molecular Sciences, 20(9), 2194.
https://doi.org/10.3390/ijms20092194